• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Trump nominates policy aide as next FDA commissioner

Trump nominates policy aide as next FDA commissioner

August 19, 2026 By Skyler Rivera

FDA HQ Adobe StockPresident Donald Trump nominated Dr. Heidi Overton, a White House domestic policy official, to serve as the next commissioner of the FDA, according to a post on his media platform Truth Social.

Overton, a physician, currently oversees the White House Domestic Policy Council as deputy director and is a proponent of the “Make America Healthy Again” (MAHA) agenda.  She previously served as chief policy officer at a conservative think tank, America First Policy Institute, where she authored articles calling for more control over prescribing abortion pills.

In his social post, Trump referred to “Dr. Heidi” as a “rockstar” who will “rapidly deliver on my priorities of faster cures, increased American innovation, major clinical trial reforms, lower drug prices, and even more MAHA wins!”

Last week, Overton was in the Oval Office when Trump signed a third executive order calling for an overhaul of the childhood vaccination schedule. During the signing, Overton said it could help states recognize the “gold standard” of federal recommendations and limit vaccines required for school enrollment.

A photo of White House Domestic Policy Council Deputy Director Heidi Overton
White House Domestic Policy Council Deputy Director Heidi Overton [Photo courtesy of America First Policy Institute]
If Overton’s nomination is confirmed, she will take over an agency without a leader for months. Former FDA Commissioner Marty Makary resigned in May after disagreeing with Trump over approving the sale of fruit-flavored e-cigarettes.

Since Makary’s resignation, FDA Deputy Commissioner for Food Kyle Diamantas led the FDA as acting commissioner. Diamantas declined to be a candidate for the permanent position.

After a turbulent summer, the agency continues to be under the public spotlight after tens of thousands of Americans became sick with cyclosporiasis, an illness caused by a parasite that spreads through feces-contaminated food and water. Outbreaks of salmonella in jalapeños and a Class I recall of eggs involving salmonella have added on to the agency’s recent chaos.

Filed Under: Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA

More recent news

  • Neptune Medical’s robotic colonoscopy system obtains FDA clearance
  • Medtronic grabs FDA clearance to add LigaSure vessel sealer to Hugo
  • Paradromics’ first study participant uses BCI for real-time speech
  • Medtronic hires former Recor CEO to run interventional cardiology group
  • Abbott wins FDA approval for Aveir VR Mini ventricular leadless pacemaker

About Skyler Rivera

Skyler Rivera is an associate editor at Arrowfly, covering medical device industry news and technology at MassDevice and Medical Design & Outsourcing. She began her career covering sports at The Athletic and MLB before transitioning to medical writing at Edwards Lifesciences. Based in Southern California, she holds a master's degree in science writing from Johns Hopkins University and a bachelor’s in broadcast journalism from Syracuse University. Connect with her on LinkedIn or email at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy